Difficulty: Medium
Average Score: 80%
Practice
The concentration of dopamine in the basal ganglia of the brain is reduced in parkinsonism.
Correct answer
A
Rationale
The correct answer is A) TRUE. In parkinsonism, the concentration of dopamine in the basal ganglia of the brain is reduced. This reduction in dopamine levels is a key characteristic of Parkinson's disease, leading to the motor symptoms associated with the condition such as tremors, rigidity, and bradykinesia.
Option B) FALSE is incorrect because it contradicts established knowledge about the pathophysiology of Parkinson's disease. Decreased dopamine levels in the basal ganglia are well-documented in research and clinical practice.
Option C) None is also incorrect as it does not provide a valid response to the question. It is important in pharmacology to understand the impact of neurotransmitter levels on various conditions to make informed decisions about treatment options.
Option D) All of the above is incorrect as it includes options that are not applicable to the question at hand.
Educationally, understanding the role of neurotransmitters like dopamine in neurological conditions such as parkinsonism is crucial for healthcare professionals, especially those involved in pharmacological interventions. This knowledge helps in selecting appropriate medications that target specific neurotransmitter pathways to alleviate symptoms and improve the quality of life for patients with Parkinson's disease.
Option B) FALSE is incorrect because it contradicts established knowledge about the pathophysiology of Parkinson's disease. Decreased dopamine levels in the basal ganglia are well-documented in research and clinical practice.
Option C) None is also incorrect as it does not provide a valid response to the question. It is important in pharmacology to understand the impact of neurotransmitter levels on various conditions to make informed decisions about treatment options.
Option D) All of the above is incorrect as it includes options that are not applicable to the question at hand.
Educationally, understanding the role of neurotransmitters like dopamine in neurological conditions such as parkinsonism is crucial for healthcare professionals, especially those involved in pharmacological interventions. This knowledge helps in selecting appropriate medications that target specific neurotransmitter pathways to alleviate symptoms and improve the quality of life for patients with Parkinson's disease.